Page 14 - Caredx News Today

02.11.2021 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CareDx, Inc (“CareDx” or “the Company”) (NASDAQ: CDNA) for violations of the securities laws. The investigation ...

30.10.2021 - Law Offices of Howard G. Smith announces an investigation on behalf of CareDx, Inc. (“CareDx” or the “Company”) (NASDAQ: CDNA) investors concerning the Company’s possible violations of the federal securities laws. On October 28, 2021, after the ...

Shares of CareDx, Inc. plummeted more than 27% on Friday, October 29, 2021, after the company disclosed that the Department of Justice and SEC have launched investigations related to CareDx’s... | October 30, 2021

In CareDx v. Natera Civ. Action No. 19-0567-CFC-CJB Consolidated, Judge Connolly ruled that the diagnostic method claimed in U. S. Pat. No. 8,703,652 and two others was a patent-ineligible natural phenomenon.

AlloSure Significantly Improves Management of High-Risk Lung Transplant Patients...

False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. ...

False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. ...

Page 260 of 260: O fato de treino é lindo lindo fdx. ❤️🤍#129293💪#128170

Partnership with OrganX to develop decision support systemsSOUTH SAN FRANCISCO, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has entered into a strategic agreement with OrganX to develop clinical decision support tools across the transplant patient journe

Study to demonstrate utility of LiverCare post-transplant surveillance for liver transplant recipientsSOUTH SAN FRANCISCO, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the enrollment of the first patient in the Molecular Assessment and Profiling of Liver Tra...